Michel Eichelbaum
Impact in
- Pharmacology top 1%
- Pharmacogenetics and Drug Metabolism
- Antibiotics Pharmacokinetics and Efficacy
- Oncology top 5%
- Drug Transport and Resistance Mechanisms
Papers in
-
- Pharmacogenetics and Drug Metabolism 6
- Antibiotics Pharmacokinetics and Efficacy 2
- Plant-based Medicinal Research 2
- Oncology 6
- Drug Transport and Resistance Mechanisms 4
- Cancer Treatment and Pharmacology 2
- Co-authors
- Martin F. Fromm (3 shared papers)Monika Hitzl (1 shared paper)Elke Schäffeler (1 shared paper)Joachim E. Fischer (1 shared paper)Matthias Schwab (1 shared paper)Siegfried Drescher (1 shared paper)Heiko van der Kuip (1 shared paper)Christiane Pauli‐Magnus (2 shared papers)
- Journals
- Biochemical Pharmacology (2 papers)Journal of Pharmacology and Experimental Therapeutics (2 papers)Pharmacogenetics and Genomics (1 paper)British Journal of Clinical Pharmacology (1 paper)Therapeutic Drug Monitoring (1 paper)
- Partner nations
- GermanyUnited StatesNigeria
In The Last Decade
Michel Eichelbaum
14 papers receiving 908 citations
Peers
Comparison fields: 5 of 82
- Pharmacology 313
- Oncology 506
- Pediatrics, Perinatology and Child Health 298
- Transplantation 21
- Biochemistry 40
Countries citing papers authored by Michel Eichelbaum
This map shows the geographic impact of Michel Eichelbaum's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michel Eichelbaum with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michel Eichelbaum more than expected).
Fields of papers citing papers by Michel Eichelbaum
This network shows the impact of papers produced by Michel Eichelbaum. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michel Eichelbaum. The network helps show where Michel Eichelbaum may publish in the future.
Co-authors
The 25 scholars most cited alongside Michel Eichelbaum, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2001 | 319 | |
| 2 | 2000 | 172 | |
| 3 | 2001 | 119 | |
| 4 | 1988 | 59 | |
| 5 | 1999 | 50 | |
| 6 | 1984 | 45 | |
| 7 | 2001 | 44 | |
| 8 | Comparative evolutionary pharmacogenetics of CYP2D6 in Ngawbe and Embera Amerindians of Panama and Colombia: role of selection versus drift in world populations. | 1999 | 43 |
| 9 | 1994 | 34 | |
| 10 | 1999 | 25 | |
| 11 | 1987 | 13 | |
| 12 | 1988 | 6 | |
| 13 | 1996 | 3 | |
| 14 | 2008 | 1 |
About Michel Eichelbaum
Michel Eichelbaum is a scholar working on Pharmacology, Oncology, Molecular Biology, Pediatrics, Perinatology and Child Health and Organic Chemistry, having authored 14 papers that have together received 933 indexed citations. Recurring topics across this work include Pharmacogenetics and Drug Metabolism (6 papers), Drug Transport and Resistance Mechanisms (4 papers), Pharmacological Effects and Toxicity Studies (3 papers), Drug Solubulity and Delivery Systems (2 papers), Cancer Treatment and Pharmacology (2 papers), Antibiotics Pharmacokinetics and Efficacy (2 papers), Drug-Induced Ocular Toxicity (2 papers) and Plant-based Medicinal Research (2 papers). The work is most often cited by research in Pharmacology (313 citations), Oncology (506 citations), Pediatrics, Perinatology and Child Health (298 citations), Transplantation (21 citations) and Biochemistry (40 citations). Michel Eichelbaum has collaborated with scholars based in Germany, United States and Nigeria. Frequent co-authors include Martin F. Fromm, Monika Hitzl, Elke Schäffeler, Joachim E. Fischer, Matthias Schwab, Siegfried Drescher, Heiko van der Kuip, Christiane Pauli‐Magnus, Thomas Mettang and Klaus Eckhardt. Their work appears in journals such as Biochemical Pharmacology, Journal of Pharmacology and Experimental Therapeutics, Pharmacogenetics and Genomics, British Journal of Clinical Pharmacology and Therapeutic Drug Monitoring.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.